Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Trevi Therapeutics, Inc. (TRVI)

13.56 -0.25 (-1.81%)
At close: October 30 at 4:00:00 PM EDT
13.56 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade TRVI on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
59,557
49,328
51,524
33,923
29,907
Operating Income
-59,557
-49,328
-51,524
-33,923
-29,907
Net Non Operating Interest Income Expense
8,396
6,536
3,598
4,357
577
Other Income Expense
-17
-31
-15
469
142
Pretax Income
-51,178
-42,823
-47,941
-29,097
-29,188
Tax Provision
-71
-64
-30
-32
-36
Net Income Common Stockholders
-51,107
-42,759
-47,911
-29,065
-29,152
Diluted NI Available to Com Stockholders
-51,107
-42,759
-47,911
-29,065
-29,152
Basic EPS
-0.35
-0.32
-0.47
-0.29
-0.45
Diluted EPS
-0.35
-0.32
-0.47
-0.29
-0.45
Basic Average Shares
148,303.29
134,747.20
101,971.87
99,033.37
64,541.91
Diluted Average Shares
148,303.29
134,747.20
101,971.87
99,033.37
64,541.91
Total Operating Income as Reported
-59,557
-49,328
-51,524
-33,923
-29,907
Total Expenses
59,557
49,328
51,524
33,923
29,907
Net Income from Continuing & Discontinued Operation
-51,107
-42,759
-47,911
-29,065
-29,152
Normalized Income
-51,107
-42,759
-47,911
-29,065
-29,005.15
Interest Income
8,396
6,536
3,602
4,748
1,740
Interest Expense
--
0
4
391
1,163
Net Interest Income
8,396
6,536
3,598
4,357
577
EBIT
-53,052
-42,823
-47,937
-28,706
-28,025
EBITDA
-52,915
-42,679
-47,790
-28,583
-27,982
Reconciled Depreciation
137
144
147
123
43
Net Income from Continuing Operation Net Minority Interest
-51,107
-42,759
-47,911
-29,065
-29,152
Total Unusual Items Excluding Goodwill
--
--
--
--
-147
Total Unusual Items
--
--
--
--
-147
Normalized EBITDA
-52,915
-42,679
-47,790
-28,583
-27,835
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-0.15
12/31/2022 - 5/7/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: